Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Artax Biopharma presents new immunomodulators

Sep. 18, 2019

B cells, T cells honored as hybrids reported

Sep. 17, 2019

FDA clears initiation of phase I trial of oral foralumab

Sep. 16, 2019

Ono Pharmaceutical patents lysophospholipid S1P5 receptor agonists

Sep. 16, 2019

A silica cage ensures thermal stability of tuberculosis vaccine candidates without refrigeration

Sep. 16, 2019

Gorilla virus makes stealth vaccine vector

Sep. 16, 2019

Moderna offers phase I data from chikungunya and CMV programs

Sep. 12, 2019

Pfizer reports preliminary data from phase II pediatric study of 20vPnC candidate

Sep. 10, 2019

Zika vaccine averts dengue cross-reactive antibody responses

Sep. 6, 2019

Positive phase II data presented for CTP-543 in patients with alopecia areata

Sep. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...